Sidekick Health Raises $55 Million, Plans To Expand Digital Chronic Disease Treatment To More Conditions

Sidekick Health, which develops digital therapeutics, raised $55 million in a Series B funding round. The company plans to expand its digital treatments to more chronic health conditions. The round was led by Novator Ventures with participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a U.S.-based strategic investor.

The company plans to use the funding to diversify its portfolio and advance the multi-chronic capabilities of its therapeutics platform. It also plans to accelerate its commercial growth in the United States. Sidekick has partnerships with pharmaceutical manufacturers. It also has a digital concierge partnership with the . . .